After receiving a warning letter from the FDA, the online retailer Amazon removed seven unregulated eye drop products from its website.
In a letter addressed to Andrew Jassy, CEO of Amazon, the FDA wrote, “These products are especially concerning from a public health perspective. Ophthalmic drug products, which are intended for administration into the eyes, in general pose a greater risk of harm to users because the route of administration for these products bypasses some of the body’s natural defenses.”
Upon removal of the products, Amazon released a statement saying, “Safety